Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 29, 2015 5:41 PM ET

Capital Markets

Company Overview of Pershing Square Capital Management, L.P.

Company Overview

Pershing Square Capital Management, L.P is an employee owned hedge fund sponsor. It provides its services to private investment funds. The firm launches and manages hedge funds for its clients. It invests in the public equity and fixed income markets across the globe. The firm employs long/short strategy to make its investments in value stocks. It employs fundamental analysis to create its portfolio. The firm obtains external research to complement its in-house research to make its investments. Pershing Square Capital Management, L.P was founded in 2004 and is based in New York City.

888 Seventh Avenue

42nd Floor

New York, NY 10019

United States

Founded in 2004





Key Executives for Pershing Square Capital Management, L.P.

Chief Executive Officer and Portfolio Manager
Age: 48
Chief Financial Officer
Age: 41
Chief Operating Officer
General Counsel and Chief Compliance Officer
Age: 47
Compensation as of Fiscal Year 2014.

Pershing Square Capital Management, L.P. Key Developments

Allergan Inc. Drops Suit Filed Against Valeant Pharmaceuticals International Inc. and Pershing Square Capital Management, L.P

Allergan Inc. ended its court battle with Valeant Pharmaceuticals International Inc. and Bill Ackman's Pershing Square Capital Management LP over an attempted takeover of the maker of the facial wrinkle-fighter Botox. The combatants filed papers in U.S. federal court in which Allergan dropped its lawsuit against Valeant and Pershing and they reciprocated by surrendering their claims.

Pershing Square Capital Management, L.P. Presents at 13D Monitor's Active-Passive Investor Summit, Apr-13-2015

Pershing Square Capital Management, L.P. Presents at 13D Monitor's Active-Passive Investor Summit, Apr-13-2015. Venue: rowne Plaza Times Square- New York City, 1605 Broadway (Btw 48th & 49th Street), New York, NY 10019, United States. Presentation Date & Speakers: Apr-13-2015, Paul C. Hilal, Partner, William Albert Ackman, Chief Executive Officer and Portfolio Manager.

Pershing To Hold Discussion With Valeant For Acquisitions

Pershing Square Capital Management, L.P. raises stake in Valeant Pharmaceuticals International, Inc. (TSX:VRX). Pershing expect to conduct discussions with Valeant and other relevant parties regarding strategic acquisitions by or joint ventures with Valeant, or other similar arrangements. These discussions would be exploratory in nature and there is no assurance that they would lead to a definitive transaction.

Similar Private Companies By Industry

Company Name Region
LPL Financial LLC United States
NCG Markets, Inc. United States
Castle Securities Corp. United States
Brock Capital Group LLC United States
VTB Capital Inc. United States

Recent Private Companies Transactions

March 9, 2015
Valeant Pharmaceuticals International, Inc.
November 17, 2014
Allergan Inc.
November 11, 2014
Zoetis Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pershing Square Capital Management, L.P., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at